Compound information
- Natural Products
- ZC2093677
- Molecular Formula
- C15H16N2OS
- Molecular Weight
- 272.098334132 g/mol
- Structure
-
- IUPAC Name
- (1S,2S)-2-methyl-N-[4-(p-tolyl)thiazol-2-yl]cyclopropanecarboxamide
- InChI
- InChI=1S/C15H16N2OS/c1-9-3-5-11(6-4-9)13-8-19-15(16-13)17-14(18)12-7-10(12)2/h3-6,8,10,12H,7H2,1-2H3,(H,16,17,18)/t10-,12-/m0/s1
- InChI Key
- IBAKFBQLUUVAOS-JQWIXIFHSA-N
- SMILES
- Cc1ccc(-c2csc(NC(=O)[C@H]3C[C@@H]3C)n2)cc1
- Source
- ZINC000003333589
Warheads
- Cyclopropane
-
ADMET Property
Physicochemical Property
| Property | Value | Property | Value |
|---|---|---|---|
| Heavy Atom Count | 19 | Ring Count | 3 |
| Heteroatom Count | 4 | Rotatable Bond Count | 3 |
| Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 1 |
| Topological Polar Surface Area | 41.99 Å2 | LogP | 4.322 |
| LogS | -5.105 | LogD | 4.809 |
Absorption
| Property | Value | Property | Value |
|---|---|---|---|
| Pgp inhibitor | 0.479 | Pgp substrate | 0.003 |
| HIA | 0.959 | F20 % | 0.993 |
| F30 % | 0.913 | Caco-2 | -4.456 |
| MDCK | -4.657 |
Distribution
| Property | Value | Property | Value |
|---|---|---|---|
| BBB Penetration | 0.024 | PPB | 91.724 |
| VD | 1.217 | Fu | 1.879 |
Metabolism
| Property | Value | Property | Value |
|---|---|---|---|
| CYP1A2 inhibitor | 0.999 | CYP1A2 substrate | 0.854 |
| CYP2A6 substrate | 0.732 | CYP2B6 substrate | 0.766 |
| CYP2C19 inhibitor | 0.662 | CYP2C19 substrate | 0.993 |
| CYP2C8 substrate | 0.868 | CYP2C9 inhibitor | 0.035 |
| CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.013 |
| CYP2D6 substrate | 0.99 | CYP2E1 substrate | 0.337 |
| CYP3A4 inhibitor | 0.147 | CYP3A4 substrate | 1.0 |
Excretion
| Property | Value | Property | Value |
|---|---|---|---|
| T1/2 | 0.13 | CL | 8.917 |
Toxicity
| Property | Value | Property | Value |
|---|---|---|---|
| hERG Blockers | 0.054 | Hepatotoxicity | 0.372 |
| Mutagenicity | 0.75 | Rat Oral Acute Toxicity | 0.132 |
| FDAMDD | 0.076 | Skin Sensitization | 0.043 |
| Carcinogenicity | 0.039 | Eye Corrosion | 0.013 |
| Eye Irritation | 0.527 | Respiratory Toxicity | 0.218 |
Environmental Toxicity
| Property | Value | Property | Value |
|---|---|---|---|
| Bioconcentration Factors | 0.91 | IGC50 | 3.931 |
| LC50FM | 5.388 | LC50DM | 4.777 |
Tox21 Pathway
| Property | Value | Property | Value |
|---|---|---|---|
| NR-AR | 0.834 | NR-AR-LBD | 0.497 |
| NR-AhR | 0.973 | NR-Aromatase | 0.115 |
| NR-ER | 0.823 | NR-ER-LBD | 0.747 |
| NR-PPAR-gamma | 0.862 | SR-ARE | 0.679 |
| SR-ATAD5 | 0.838 | SR-HSE | 0.607 |
| SR-MMP | 0.975 | SR-p53 | 0.777 |
Similar covalent drugs
No similar covalent drugs found for this compound.